Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, recall and potato chip
FDA upgrades Frito-Lay potato chips recall to highest risk level due to undeclared milk
Federal regulators have upgraded a product recall of Lay's Classic Potato Chips to the highest risk level for a batch that may contain undeclared milk ingredients. Last month, Frito-Lay issued a recall warning that more than 6,
Broccoli Recall Update as FDA Sets Highest Risk Level Over Bacteria Fears
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been given the U.S. Food and Drug Administration (FDA)'s highest risk level.
FDA upgrades Oregon, Washington recall for Lay's Classic Potato Chips to highest level
The FDA upgraded a recall for Lay's Classic Potato Chips to the highest risk level for packages distributed in Oregon and Washington.
FDA’s Proposed Ban On Cigarettes Will Fail Just
Trump admin's FDA withdraws proposed federal rule to ban menthol cigarettes
Trump's FDA moved to squash a proposed rule to ban menthol cigarettes just one day after the president was sworn in, angering anti-smoking advocates.
The FDA’s Proposed Ban On Cigarettes Will Fail Just As Prohibition Did
The prohibition of liquor a century ago was a disaster. Yet the FDA is setting up a repeat with its proposed ban of cigarettes.
Trump Rolls Back FDA Menthol Ban
The first week of Donald Trump's second term was so full of executive orders that it was hard to keep track of what was changing. With so many headline-making declarations—both good and bad—it was easy to miss one stellar piece of policy pushed through: the withdrawal of the Food and Drug Administration's proposal to ban menthol tobacco and
type 2 diabetes, chronic kidney disease and FDA
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
US FDA Approves Novo Nordisk's Diabetes Drug to Reduce Risk of Worsening Kidney Disease
(Reuters) - Novo Nordisk said on Tuesday the U.S. FDA has approved its diabetes drug Ozempic to reduce the risk of worsening kidney disease and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease.
BioSpace
1h
How Might the FDA Evolve Under RFK Jr. and Makary?
Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...
9h
Check your fridge: FDA issues Class 1 recall for salmon sold at popular retail chain
The fish was initially recalled in October due to laboratory testing confirming Listeria monocytogenes on Oct. 21, 2024, ...
Medical News Today
1d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
1d
FDA Approves AstraZeneca And Daiichi Sankyo's ENHERTU For HER2-Low/Ultralow Breast Cancer
The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Trump
Food and Drug Administration
United States
recall
Ozempic
Feedback